Evaxion A EVAX
NASDAQ EVAX
$3.31 +0.03 (+0.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evaxion A (EVAX) Consolidated Net Income (2020 - 2026)

Evaxion A's (EVAX) quarterly Consolidated Net Income came in at -$4.1 million in Q1 2026, down 106.77% YoY from $60.0 million in Q1 2025, and up 36.83% on a QoQ basis from -$6.4 million in Q4 2025.

Evaxion A (EVAX) Consolidated Net Income (2020 - 2026) Analysis & Trends

Evaxion A (EVAX) has 7 years of Consolidated Net Income data on file, last reported at -$4.1 million in Q1 2026.

  • Quarterly Consolidated Net Income fell 106.77% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.6 million (up 20.75% YoY) and the FY2025 annual result came in at -$9.5 million, up 21.58% from the prior year.
  • Consolidated Net Income grew to -$4.1 million in Q1 2026, from -$6.4 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $4.1 million in Q3 2025 to a low of -$7.2 million in Q4 2022.
  • A 5-year average of -$3.8 million and a median of -$4.9 million in 2023 frame the typical range for Consolidated Net Income.
  • Annual changes were most pronounced in 2023 — Consolidated Net Income plunged 680.8% — and 2025, when it surged 292.15%.
  • Tracing EVAX's Consolidated Net Income over 5 years: stood at -$7.2 million in 2022, then soared by 32.43% to -$4.9 million in 2023, then climbed by 14.31% to -$4.2 million in 2024, then tumbled by 53.84% to -$6.4 million in 2025, then surged by 36.83% to -$4.1 million in 2026.
  • The last three Consolidated Net Income figures came in at -$4.1 million (Q1 2026), -$6.4 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -174.37 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Evaxion A 27.61 Mn 27.61 Mn - -4.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.06 Mn
Dec 31, 2025 -6.43 Mn
Sep 30, 2025 4.09 Mn
Jun 30, 2025 -5.22 Mn
Mar 31, 2025 -1.96 Mn
Dec 31, 2024 -4.18 Mn
Sep 30, 2024 -2.13 Mn
Jun 30, 2024 -6.40 Mn
Mar 31, 2024 758,000.00
Dec 31, 2023 -4.88 Mn
Sep 30, 2023 -6.07 Mn
Jun 30, 2023 -6.13 Mn
Mar 31, 2023 -6.63 Mn
Dec 31, 2022 -7.22 Mn
Sep 30, 2022 -6.09 Mn
Jun 30, 2022 -1.78 Mn
Mar 31, 2022 -849,000.00
Dec 31, 2021 -5.72 Mn
Sep 30, 2021 -19.16 Mn
Jun 30, 2021 -653,000.00